BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Policy

  J&J Hit With Federal Subpoenas Over Baby Powder Contamination Allegations

  Johnson & Johnson’s iconic talcum powder product has been the subject of lawsuits and a scathing report that indicated the company allegedly knew that carcinogenic asbestos was sometimes found in the product. As a result, the company has received subpoenas from the federal government.

  February 21, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Morphic and Janssen to Collaborate in Deal Worth up to $750 Million

  Waltham, Mass.-based Morphic Therapeutic and Janssen Biotech, a division of Johnson & Johnson, entered into a collaborative deal to develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies.

  February 21, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Meet the Pharma Reps About to Face the Senate Over Pricing Concerns

  Seven pharma executives will enter the Congressional crucible next week as they face questions and concerns over the rising costs of prescription drugs.

  February 21, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Job Trends

  Companies Announce Job Openings in the Wake of Expansions - Some Cuts Were Made, Too

  If you’re in the pharma or biotech industry and are looking for work, multiple companies have announced expansions of their employee pool over the past few days. BioSpace rounds up a few of the announcements.

  February 21, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Bio NC

  J&J Earns Spot in Fortune’s Top 50 Most Respected Companies

  It’s nice to be admired. Fortune released its list of the most respected companies across the globe and one pharma company made the top 50 list.

  February 21, 2019

   · 

  4 min read

   · 

  Alex Keown
• 

  Job Trends

  BioSpace Movers and Shakers: Feb. 22

  Companies make leadership changes to executive teams, including additions at Allergan, Surmodics, Arix, RedHill, Cerevel, Enzyvant, and more.

  February 21, 2019

   · 

  5 min read

   · 

  Alex Keown
• 

  Drug Development

  Feb. 22 Research Roundup: Hearing Restoration, Depression, Marrow Transplants and Aging and MS

  Research is the cornerstone of new medications that treat numerous needs across the globe. Here’s a look at a few of the interesting research stories that crossed BioSpace’s slice of the Internet.

  February 21, 2019

   · 

  3 min read

   · 

  Alex Keown
• Deals

  Recipharm AB publishes its report for the fourth quarter and full year 2018

  Recipharm announced the intention to end operations in Ashton-under-Lyne, United Kingdom

  February 21, 2019

   · 

  6 min read
• Pharm Country

  MorphoSys to Present at Upcoming Investor Conference

  MorphoSys AG will present at the following conference.

  February 21, 2019

   · 

  3 min read
• 

  Drug Development

  Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

  DTX401 Response in Time to Hypoglycemia and Improved Glucose Control Maintained or Improved in All Three Patients

  February 21, 2019

   · 

  6 min read